933034-89-0

Basic information

• Product Name: 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride
• Synonyms: 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride
• CAS NO: 933034-89-0
• Molecular Formula: C₆H₃BrClN₃*ClH
• Molecular Weight: 268.92606
• Mol File: 933034-89-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride(933034-89-0)
• EPA Substance Registry System: 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride(933034-89-0)

Safety Data

• Hazardous Substances Data: 933034-89-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research and Development:
8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride is used as a chemical compound in pharmaceutical research and development for its potential therapeutic applications in various diseases. Its unique structure and properties make it a promising candidate for drug discovery and development.
Used in Cancer Treatment:
8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride is used as a potential therapeutic agent in cancer treatment. Its specific chemical structure allows it to target and interact with biological molecules involved in cancer progression, making it a candidate for the development of new anticancer drugs.
Used in Neurological Disorder Treatment:
8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride is also used as a potential therapeutic agent in the treatment of neurological disorders. Its ability to modulate specific biological pathways and targets associated with neurological conditions makes it a candidate for the development of new treatments for these disorders.
Overall, 8-bromo-6-chloroimidazo[1,2-b]pyridazine hydrochloride is a versatile chemical with potential applications in drug discovery and development, particularly in the areas of cancer and neurological disorder treatment. Its unique structure and properties, along with its enhanced stability and solubility due to its hydrochloride form, make it a promising candidate for further research and development.

Upstream product

• 107-20-0 2-chloroethanal 
• 446273-59-2 4-bromo-6-chloro-3-pyridazineamine 

Downstream Products

• 933035-31-5 3,8-dibromo-6-chloroimidazo[1,2-b]pyridazine 
• 933035-05-3 6-chloro-N-(4-methoxy-benzyl)-imidazo[1,2-b]pyridazin-8-amine 
• 1263423-94-4 N-cyclopropyl-4-(8-((tetrahydro-2H-pyran-4-yl)methylamino)-6-(1,1,1-trifluoro-2-methylpropan-2-ylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 
• 1263423-52-4 4-(6-(tert-butylamino)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide 
• 1263423-27-3 N-cyclopropyl-4-(6-(isopropylamino)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 
• 1263423-18-2 4-(6-(cyclopentylamino)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide 
• 1263423-17-1 4-(6-(cyclohexylamino)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)-N-cyclopropylbenzamide 
• 1263423-50-2 N-cyclopropyl-4-(6-(phenylamino)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 
• 1263424-19-6 N-cyclopropyl-4-(6-(2-hydroxyphenoxy)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 
• 1263424-11-8 N-cyclopropyl-4-(6-(2-fluorophenoxy)-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 
• 1263424-10-7 N-cyclopropyl-4-(6-phenoxy-8-((tetrahydro-2H-pyran-4-yl)methylamino)imidazo[1,2-b]pyridazin-3-yl)benzamide 

Relevant articles and documents

HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE

Disclosed herein are compounds and methods which may be useful as inhibitors of GPRl 19 for the treatment or prevention of diseases including cardiovascular and metabolic diseases.

Fused heterocyclic compounds useful as kinase modulators

Compounds having the formula (1), and enantiomers, and diastereomers, pharmaceutically-acceptable salts, thereof, are usefuil as kinase modulators, including MK2 modulation, wherein one of E and F is a nitrogen atom and the other of E and F is a carbon atom, Z is N or CR3, and R1, R2, R3, X and Y are as defined herein.